Global Multiple Sclerosis Drugs Sales Market Report 2016

October 2016 | 106 pages | ID: G4CF348DB28EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Multiple Sclerosis Drugs

Revenue, means the sales value of Multiple Sclerosis Drugs

This report studies sales (consumption) of Multiple Sclerosis Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Biogen
• Teva Pharmaceutical
• Merck KGaA
• Novartis
• Bayer
• Sanofi
• Acorda Therapeutics
• Questcor Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Multiple Sclerosis Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Multiple Sclerosis Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Multiple Sclerosis Drugs Sales Market Report 2016

1 MULTIPLE SCLEROSIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Multiple Sclerosis Drugs
1.2 Classification of Multiple Sclerosis Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Multiple Sclerosis Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Multiple Sclerosis Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Multiple Sclerosis Drugs (2011-2021)
  1.5.1 Global Multiple Sclerosis Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL MULTIPLE SCLEROSIS DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Multiple Sclerosis Drugs Market Competition by Manufacturers
  2.1.1 Global Multiple Sclerosis Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Multiple Sclerosis Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Multiple Sclerosis Drugs (Volume and Value) by Type
  2.2.1 Global Multiple Sclerosis Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Multiple Sclerosis Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Multiple Sclerosis Drugs (Volume and Value) by Regions
  2.3.1 Global Multiple Sclerosis Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Multiple Sclerosis Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Multiple Sclerosis Drugs (Volume) by Application

3 UNITED STATES MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Multiple Sclerosis Drugs Sales and Value (2011-2016)
  3.1.1 United States Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
3.2 United States Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
3.3 United States Multiple Sclerosis Drugs Sales and Market Share by Type
3.4 United States Multiple Sclerosis Drugs Sales and Market Share by Application

4 CHINA MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Multiple Sclerosis Drugs Sales and Value (2011-2016)
  4.1.1 China Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
4.2 China Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
4.3 China Multiple Sclerosis Drugs Sales and Market Share by Type
4.4 China Multiple Sclerosis Drugs Sales and Market Share by Application

5 EUROPE MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Multiple Sclerosis Drugs Sales and Value (2011-2016)
  5.1.1 Europe Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
5.2 Europe Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
5.3 Europe Multiple Sclerosis Drugs Sales and Market Share by Type
5.4 Europe Multiple Sclerosis Drugs Sales and Market Share by Application

6 JAPAN MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Multiple Sclerosis Drugs Sales and Value (2011-2016)
  6.1.1 Japan Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
6.2 Japan Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
6.3 Japan Multiple Sclerosis Drugs Sales and Market Share by Type
6.4 Japan Multiple Sclerosis Drugs Sales and Market Share by Application

7 GLOBAL MULTIPLE SCLEROSIS DRUGS MANUFACTURERS ANALYSIS

7.1 Biogen
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Biogen Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Teva Pharmaceutical
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 106 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Teva Pharmaceutical Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Merck KGaA
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 128 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Merck KGaA Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Oct Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Novartis Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Bayer
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bayer Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Sanofi
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Sanofi Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Acorda Therapeutics
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Acorda Therapeutics Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Questcor Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview

8 MULTIPLE SCLEROSIS DRUGS MAUFACTURING COST ANALYSIS

8.1 Multiple Sclerosis Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Multiple Sclerosis Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Multiple Sclerosis Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MULTIPLE SCLEROSIS DRUGS MARKET FORECAST (2016-2021)

12.1 Global Multiple Sclerosis Drugs Sales, Revenue Forecast (2016-2021)
12.2 Global Multiple Sclerosis Drugs Sales Forecast by Regions (2016-2021)
12.3 Global Multiple Sclerosis Drugs Sales Forecast by Type (2016-2021)
12.4 Global Multiple Sclerosis Drugs Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Multiple Sclerosis Drugs
Table Classification of Multiple Sclerosis Drugs
Figure Global Sales Market Share of Multiple Sclerosis Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Multiple Sclerosis Drugs
Figure Global Sales Market Share of Multiple Sclerosis Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure China Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure Global Multiple Sclerosis Drugs Sales and Growth Rate (2011-2021)
Figure Global Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Table Global Multiple Sclerosis Drugs Sales of Key Manufacturers (2011-2016)
Table Global Multiple Sclerosis Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Multiple Sclerosis Drugs Sales Share by Manufacturers
Figure 2016 Multiple Sclerosis Drugs Sales Share by Manufacturers
Table Global Multiple Sclerosis Drugs Revenue by Manufacturers (2011-2016)
Table Global Multiple Sclerosis Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table 2016 Global Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table Global Multiple Sclerosis Drugs Sales and Market Share by Type (2011-2016)
Table Global Multiple Sclerosis Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Multiple Sclerosis Drugs by Type (2011-2016)
Figure Global Multiple Sclerosis Drugs Sales Growth Rate by Type (2011-2016)
Table Global Multiple Sclerosis Drugs Revenue and Market Share by Type (2011-2016)
Table Global Multiple Sclerosis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Multiple Sclerosis Drugs by Type (2011-2016)
Figure Global Multiple Sclerosis Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Multiple Sclerosis Drugs Sales and Market Share by Regions (2011-2016)
Table Global Multiple Sclerosis Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Multiple Sclerosis Drugs by Regions (2011-2016)
Figure Global Multiple Sclerosis Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Multiple Sclerosis Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Multiple Sclerosis Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Multiple Sclerosis Drugs by Regions (2011-2016)
Figure Global Multiple Sclerosis Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Multiple Sclerosis Drugs Sales and Market Share by Application (2011-2016)
Table Global Multiple Sclerosis Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Multiple Sclerosis Drugs by Application (2011-2016)
Figure Global Multiple Sclerosis Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure United States Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure United States Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table United States Multiple Sclerosis Drugs Sales by Manufacturers (2011-2016)
Table United States Multiple Sclerosis Drugs Market Share by Manufacturers (2011-2016)
Table United States Multiple Sclerosis Drugs Sales by Type (2011-2016)
Table United States Multiple Sclerosis Drugs Market Share by Type (2011-2016)
Table United States Multiple Sclerosis Drugs Sales by Application (2011-2016)
Table United States Multiple Sclerosis Drugs Market Share by Application (2011-2016)
Figure China Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure China Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure China Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table China Multiple Sclerosis Drugs Sales by Manufacturers (2011-2016)
Table China Multiple Sclerosis Drugs Market Share by Manufacturers (2011-2016)
Table China Multiple Sclerosis Drugs Sales by Type (2011-2016)
Table China Multiple Sclerosis Drugs Market Share by Type (2011-2016)
Table China Multiple Sclerosis Drugs Sales by Application (2011-2016)
Table China Multiple Sclerosis Drugs Market Share by Application (2011-2016)
Figure Europe Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure Europe Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table Europe Multiple Sclerosis Drugs Sales by Manufacturers (2011-2016)
Table Europe Multiple Sclerosis Drugs Market Share by Manufacturers (2011-2016)
Table Europe Multiple Sclerosis Drugs Sales by Type (2011-2016)
Table Europe Multiple Sclerosis Drugs Market Share by Type (2011-2016)
Table Europe Multiple Sclerosis Drugs Sales by Application (2011-2016)
Table Europe Multiple Sclerosis Drugs Market Share by Application (2011-2016)
Figure Japan Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure Japan Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table Japan Multiple Sclerosis Drugs Sales by Manufacturers (2011-2016)
Table Japan Multiple Sclerosis Drugs Market Share by Manufacturers (2011-2016)
Table Japan Multiple Sclerosis Drugs Sales by Type (2011-2016)
Table Japan Multiple Sclerosis Drugs Market Share by Type (2011-2016)
Table Japan Multiple Sclerosis Drugs Sales by Application (2011-2016)
Table Japan Multiple Sclerosis Drugs Market Share by Application (2011-2016)
Table Biogen Basic Information List
Table Biogen Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Multiple Sclerosis Drugs Global Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Multiple Sclerosis Drugs Global Market Share (2011-2016)
Table Merck KGaA Basic Information List
Table Merck KGaA Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck KGaA Multiple Sclerosis Drugs Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Multiple Sclerosis Drugs Global Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Multiple Sclerosis Drugs Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Multiple Sclerosis Drugs Global Market Share (2011-2016)
Table Acorda Therapeutics Basic Information List
Table Acorda Therapeutics Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Acorda Therapeutics Multiple Sclerosis Drugs Global Market Share (2011-2016)
Table Questcor Pharmaceuticals Basic Information List
Table Questcor Pharmaceuticals Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Questcor Pharmaceuticals Multiple Sclerosis Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Sclerosis Drugs
Figure Manufacturing Process Analysis of Multiple Sclerosis Drugs
Figure Multiple Sclerosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
Table Major Buyers of Multiple Sclerosis Drugs
Table Distributors/Traders List
Figure Global Multiple Sclerosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Multiple Sclerosis Drugs Sales Forecast by Regions (2016-2021)
Table Global Multiple Sclerosis Drugs Sales Forecast by Type (2016-2021)
Table Global Multiple Sclerosis Drugs Sales Forecast by Application (2016-2021)